Private equity firms Bain Capital and Cinven have enlisted a group of banks to assist in considering various options for German drugmaker Stada Arzneimittel AG, including a potential sale of the company, according to individuals familiar with the matter.
The sources spoke on the condition of anonymity in order to protect confidential information.
The transaction is anticipated to occur next year and could potentially value Stada at approximately €10 billion ($10.5 billion) or more, as per the insiders.
Continue with Facebook Continue with Google